Skip to content
Clinical Trials – home

Falu lasarett

Verified siteinfo

Sweden Lasarettvagen 10, 79182 Falun, Sweden

  • 2 trials recruiting
  • Cardiac ventricular thrombosis · Acute myocardial infarction · Rheumatoid arthritis
  • Adult patients

About Specializations

Falu lasarett in Falun, Sweden specialises in clinical trials of conditions such as Cardiac ventricular thrombosis, Acute myocardial infarction, Rheumatoid arthritis, Dyslipidaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology

The medical center is at the forefront of rheumatology research, focusing on innovative treatments for rheumatoid arthritis. The institution is dedicated to exploring the efficacy of both conventional and biologic therapies, aiming to enhance patient outcomes through personalized treatment strategies.

  • Active Conventional Therapy (ACT)
  • Biologic Therapies
  • De-escalation Strategies

By comparing various therapeutic approaches, the center contributes significantly to the understanding of remission achievement in rheumatoid arthritis, paving the way for more effective and tailored treatment plans.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Lasarettvagen 1079182 FalunSweden
Recruiting now
2 trials
Conditions studied
5
Partner status
Verified site

More sites in FalunSweden

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska Institutet

Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Plasma cell myeloma

Not recruiting

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Pfizer Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.